Jasper Therapeutics, Inc.
JSPR
$0.46
$0.00-0.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.80M | -91.02M | -90.92M | -78.78M | -71.27M |
| Total Depreciation and Amortization | 1.06M | 1.01M | 1.32M | 1.36M | 1.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.51M | 7.93M | 8.36M | 7.83M | 7.11M |
| Change in Net Operating Assets | -4.92M | 5.65M | 7.76M | -119.00K | 184.00K |
| Cash from Operations | -77.16M | -76.43M | -73.48M | -69.71M | -62.60M |
| Capital Expenditure | -7.00K | -103.00K | -377.00K | -527.00K | -552.00K |
| Sale of Property, Plant, and Equipment | 12.00K | 32.00K | 32.00K | 24.00K | 20.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 5.00K | -71.00K | -345.00K | -503.00K | -532.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34.55M | 34.90M | 6.52M | 535.00K | 47.88M |
| Repurchase of Common Stock | -340.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 34.21M | 34.90M | 6.52M | 535.00K | 47.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.95M | -41.60M | -67.31M | -69.68M | -15.25M |